Literature DB >> 1715793

Alpha-thalassemia resulting from deletion of regulatory sequences far upstream of the alpha-globin structural genes.

L Romao1, L Osorio-Almeida, D R Higgs, J Lavinha, S A Liebhaber.   

Abstract

We describe an alpha-thalassemia determinant in which alpha-globin expression is silenced by a deletion located 27 kb 5' to the transcription start site of the alpha 2-globin gene. This alpha-thalassemic determinant, (alpha alpha)MM, is a member of a newly described group of thalassemic mutations resulting from deletion of locus-controlling sequences critical to globin gene expression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715793

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  A globin enhancer acts by increasing the proportion of erythrocytes expressing a linked transgene.

Authors:  H G Sutherland; D I Martin; E Whitelaw
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

2.  Analysis of the human alpha-globin gene cluster in transgenic mice.

Authors:  J A Sharpe; D J Wells; E Whitelaw; P Vyas; D R Higgs; W G Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

3.  Human alpha-globin gene expression is silenced by terminal truncation of chromosome 16p beginning immediately 3' of the zeta-globin gene.

Authors:  L Romao; F Cash; I Weiss; S Liebhaber; M Pirastu; R Galanello; A Loi; E Paglietti; P Ioannou; A Cao
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

4.  Analysis of the human alpha globin upstream regulatory element (HS-40) in transgenic mice.

Authors:  J A Sharpe; P S Chan-Thomas; J Lida; H Ayyub; W G Wood; D R Higgs
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

5.  Rare α0-thalassemia deletions detected by MLPA in five unrelated Brazilian patients.

Authors:  Natália O Mota; Elza M Kimura; Roberta D Ferreira; Gisele A Pedroso; Dulcinéia M Albuquerque; Daniela M Ribeiro; Magnun N N Santos; Cristina M Bittar; Fernando F Costa; Maria de Fatima Sonati
Journal:  Genet Mol Biol       Date:  2017-10-02       Impact factor: 1.771

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.